about
Anemia and iron deficiency in gastrointestinal and liver conditionsAnti-inflammatory drugs modulate C1q secretion in human peritoneal macrophages in vitroHMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitroMolecular and catalytic properties of three rat leukotriene C(4) synthase homologs[Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies].Deoxycholic acid stimulates migration in colon cancer cells.PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate.Hydroxylamine-containing inhibitors of polyamine biosynthesis and impairment of colon cancer cell growth.Butyrate-induced differentiation of Caco-2 cells occurs independently from p27.p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression.Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cellsThe new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory coursesFERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.Diagnosis and management of iron deficiency anemia in patients with IBD.Health-related quality of life in adult coeliac disease in Germany: results of a national survey.Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease.Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.[Diagnosis of steatorrhea]Low dose methotrexate in inflammatory bowel disease: current status and future directions.Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemiaEfficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice.Coeliac Disease - New Pathophysiological Findings and Their Implications for TherapyEnteral nutrition by endoscopic means; I. Techniques, indications, types of enteral feed.Enteral Nutrition by Endoscopic Means; II. Complications and Management.Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.Impact of Severe Obesity and Weight Loss on Systolic Left Ventricular Function and Morphology: Assessment by 2-Dimensional Speckle-Tracking Echocardiography.Rapid postabsorptive metabolism of nicotinic acid in rat small intestine may affect transport by metabolic trapping.Stool test for colorectal cancer screening--it's time to move!Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity.Management of inflammatory bowel diseases during pregnancy.An etiologic profile of anemia in 405 geriatric patients.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.Review article: The nutritional and pharmacological consequences of obesity surgery.European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos.
P50
Q28069820-DB66EA55-C620-46E6-87A7-14B8EF5DE885Q28193515-4C770D2F-72B2-49A8-80F9-CE39EEB70EB6Q28201997-F392A008-2BF9-47D6-B17C-7C2602F7CC28Q28479065-6F264B80-6D07-46F2-91C9-167FA21EF047Q28564308-39EBBCFA-69DB-4F11-8F7E-46AA7DBA4FCAQ30864798-B41BD521-7042-4D24-9684-4B144E6B4045Q31002818-2E16647D-2459-4823-976A-4BEA79E548F3Q31389114-635CEF06-F0C4-4E4A-9CCD-8FC69B117599Q31859979-759020C1-0069-48DD-AE6E-60CB2FA1096BQ31952955-48EB4281-817E-4287-BC12-394CC9487373Q33208259-5A9BA5B2-D232-4945-BE91-3B71096C6D3AQ33232508-FC6492DF-E9D6-4BF4-8E95-0E63E1281042Q33254277-6FCE86D4-7249-41B9-A733-D261047F6356Q33271908-45D94810-5B21-44D8-A9B1-FAFAA8EFDC86Q33301251-DB5F697A-8465-442B-8A9C-B4DA9A411F94Q33375214-4A3DAD51-8367-41BA-825C-2AE55076E552Q33858229-FBB37E23-E7A9-47FE-9F32-D56C761B4CFFQ34027434-6F45BCA5-B01D-4719-B77D-3FD83EA8A6B8Q34141999-B1C677ED-4190-4C27-9433-717F779447F6Q34537933-15443B5F-2679-4CDF-AE42-2471ECBADBAEQ34624365-BE3ECB16-007B-43EF-930D-B9D6AED3CB1DQ34710712-721BB6C8-C279-4B24-B758-2A96F11C7E6FQ34726704-F8BD6CAA-0DC8-4052-AA5A-256B7005D5DEQ35090036-F854FB83-95CC-4453-A85B-978C34CAE958Q35594086-2A02BD13-BE28-4E9C-92C3-2360A434EA49Q35864436-02E3A362-81EF-4D34-B7D1-CE7BB2E0CDC0Q35885793-96AF1A19-F281-46B9-9942-79B180C31038Q35981323-955E8D71-BE51-442F-B134-2F58833EBFB8Q35981330-E205ACA6-7CFF-4055-B279-E59CC3D613C0Q36097866-5D0672E0-3B03-4A3E-935F-7486FA8CAE2EQ36661299-13617AAC-BCCD-4268-AB1D-0C542231D01DQ36760094-1642601C-612F-446D-88E9-3424AE7140A1Q37392689-9139A5D4-4FBB-4F9B-95EE-C19F1FF1714CQ37582756-ECB853C3-0BC6-4E40-BE79-ECE6F10B8012Q37604766-9F286458-C33A-4A62-8574-8C7618C9DBCBQ37636123-4B790807-D9E8-43C0-B4A3-44326F0256C5Q38049779-2179B230-110A-48B7-8D87-F3D036EB0E7EQ38235543-BBFFF572-A97B-42BA-BA94-72348FF8BC4FQ38291941-9614EF40-2437-4A8F-A1A5-440A557D68EAQ38356224-26CC6201-1AC4-4D6A-9CF4-2F138AA6C972
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jürgen Stein
@ast
Jürgen Stein
@en
Jürgen Stein
@es
Jürgen Stein
@nl
Jürgen Stein
@sl
type
label
Jürgen Stein
@ast
Jürgen Stein
@en
Jürgen Stein
@es
Jürgen Stein
@nl
Jürgen Stein
@sl
prefLabel
Jürgen Stein
@ast
Jürgen Stein
@en
Jürgen Stein
@es
Jürgen Stein
@nl
Jürgen Stein
@sl
P106
P31
P496
0000-0003-3558-3341